Pharma-Bio Serv (PBSV) Assets Average (2011 - 2026)

Pharma-Bio Serv's Assets Average history runs 14 years deep, the most recent figure standing at $12.5 million for Q2 2026.

• Assets Average for Q2 2026 came in at $12.5 million, down 16.45% year-over-year; the trailing twelve-month figure through Apr 2026 was $12.5 million (down 16.45% YoY), and the FY2025 annual result was $15.0 million, down 17.27% from the prior year.
• Assets Average came in at $12.5 million for Q2 2026 at Pharma-Bio Serv, down from $13.6 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $23.0 million in Q1 2022 to a low of $12.5 million in Q2 2026.
• A 5-year average of $18.0 million and a median of $18.8 million in 2024 frame the typical range for Assets Average.
• Across the five-year window, Assets Average retreated 28.33% in 2022 and climbed 0.67% in 2023, its largest moves.
• Over 5 years, Assets Average stood at $20.5 million in 2022, then declined by 1.91% to $20.1 million in 2023, then fell by 18.88% to $16.3 million in 2024, then slipped by 16.47% to $13.6 million in 2025, then declined by 8.04% to $12.5 million in 2026.
• The last three Assets Average figures came in at $12.5 million (Q2 2026), $13.6 million (Q1 2026), and $13.6 million (Q4 2025), per Business Quant data.